Cargando…
The Third Case of Cabergoline-Associated Valvulopathy: The Value of Routine Cardiovascular Examination for Screening
A decade after the alarming association of cabergoline-associated valvulopathy (CAV) in Parkinson disease, only two confirmed cases have occurred in patients with prolactinoma. Routine screening for CAV by echocardiography has not proved to be of diagnostic utility, has several limitations, and is n...
Autores principales: | Caputo, Carmela, Prior, David, Inder, Warrick J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070051/ https://www.ncbi.nlm.nih.gov/pubmed/30083627 http://dx.doi.org/10.1210/js.2018-00139 |
Ejemplares similares
-
Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
por: Hayes, Annabelle G, et al.
Publicado: (2022) -
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017) -
Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation
por: Yedinak, Chris G., et al.
Publicado: (2014) -
Thyrotoxic Valvulopathy: Case Report and Review of the Literature
por: Pierre, Keniel, et al.
Publicado: (2017) -
Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)